Consulting has an in increasing role to play in the pharma sector. BJ Richards, Source Global Research offers a pharma executive’s guide to the service.
You don’t need us to tell you that Europe’s pharma & biotech industry has a lot on its plate. The demand to develop innovative drugs and devices, maximising the profitability of R&D investments, improving efficiency and slashing costs, plus the endless crush of regulatory demands. It’s an agenda that keeps pharma executives and their teams scrambling. Now more than ever, it’s driving work for Europe’s management consultants. Indeed, in markets across Europe, consulting to the pharma & biotech industry is not only on the rise but growing a good deal faster than consulting as a whole, a trend we expect will continue for the foreseeable future.